Exelixis director granted 8,367 RSUs

Beckerle Mary C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Beckerle Mary C reported acquisition or exercise transactions in this Form 4 filing.

EXELIXIS, INC. director Mary C. Beckerle received a grant of 8,367 restricted stock units (RSUs), each equal to one share of common stock. The award was granted under the 2017 Equity Incentive Plan and will vest in full on May 27, 2027, subject to continuous service. Following this grant, she holds 25,891 shares and RSUs, including 16,079 shares issuable upon future RSU vesting.

Insights

Equity compensation analyst

Routine RSU compensation grant with time-based vesting.

The filing shows director Mary C. Beckerle receiving 8,367 RSUs at no cash cost, under Exelixis's 2017 Equity Incentive Plan. This is standard equity-based compensation rather than an open-market share purchase.

The RSUs cliff-vest 100% on May 27, 2027, contingent on continued service, which aligns the director’s incentives with long-term company performance. After the grant, she has 25,891 shares and RSUs in total, indicating a modest but meaningful equity stake.

Insider Trade Summary

Grant/Award: 8,367 shares

Grant/Award 1 txn

Insider Beckerle Mary C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	$0.00

Holdings After Transaction: Common Stock — 25,891 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.
2. F2. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSUs granted: 8,367 RSUs Grant price per share: $0.00 per share Total holdings after grant: 25,891 shares/RSUs +2 more

5 metrics

RSUs granted 8,367 RSUs Grant to director on May 27, 2026

Grant price per share $0.00 per share Equity award, no cash paid

Total holdings after grant 25,891 shares/RSUs Director’s position following reported transaction

Unvested RSU shares included 16,079 shares Shares to be issued upon RSU vesting

Vesting date May 27, 2027 100% of 8,367 RSUs vest if service continues

Key Terms

restricted stock units ("RSUs"), 2017 Equity Incentive Plan, economic equivalent, continuous service

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2017 Equity Incentive Plan financial

"granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

economic equivalent financial

"Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock"

continuous service financial

"will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did EXELIXIS (EXEL) director Mary C. Beckerle report on this Form 4?

She reported receiving 8,367 restricted stock units (RSUs) of EXELIXIS common stock as a grant. These RSUs were issued at no cash cost as part of the company’s 2017 Equity Incentive Plan and represent additional equity-based compensation.

When do Mary C. Beckerle’s new EXEL RSUs vest?

The 8,367 RSUs granted to Mary C. Beckerle vest 100% on May 27, 2027. Vesting is conditioned on her continuous service with EXELIXIS through that date, making this a time-based incentive tied to long-term board service.

How many EXELIXIS shares and RSUs does Mary C. Beckerle hold after this grant?

After the reported grant, she holds a total of 25,891 shares and RSUs in EXELIXIS. This total includes 16,079 shares that will be issued upon the future vesting of RSUs already outstanding in her equity awards.

Is Mary C. Beckerle buying or selling EXELIXIS stock in this Form 4?

She is not buying or selling shares on the open market; she is receiving an equity award. The Form 4 reflects a grant of 8,367 RSUs as compensation, with no reported market purchases or sales of EXELIXIS common stock.

Under which plan were Mary C. Beckerle’s EXEL RSUs granted?

The RSUs were granted under the EXELIXIS, INC. 2017 Equity Incentive Plan. This plan provides equity-based awards such as RSUs to directors and employees, aligning their interests with shareholders by linking compensation to company stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 05:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beckerle Mary C

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		8,367(1)	A	$0	25,891(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)